Educational  ·  Mechanism-Led

Klotho, what the science actually shows

Klotho peptide fragments are synthetic segments of the Klotho protein studied for anti-aging and kidney protection. Not FDA-approved. Evidence base: primarily preclinical animal data; no human trials identified.

Named after the Greek goddess who spins the thread of life. A protein discovered in 1997 that extends lifespan in mice and enhances cognition. UCSF research is driving the field. Human translation is in its earliest stages.

1012
Amino acids (full)
1997
First described
Not
FDA approved
Scroll
On this page
  1. What Klotho is. And where it comes from
  2. Mechanism, in plain English
  3. What the evidence shows
  4. FDA status
  5. Common synonyms researchers use
  6. Safety and adverse-event landscape
  7. Frequently asked questions
Mechanism
Suppresses insulin/IGF-1 signaling, reduces oxidative stress, enhances synaptic plasticity, modulates Wnt signaling and FGF23/phosphate metabolism.
Evidence Level
Primarily preclinical (★★☆☆☆). Strong animal data for lifespan extension and cognition. Human data is observational and very early.
FDA Status
Not FDA-approved. No Klotho-based therapeutic has entered human clinical trials. Research compound and biomarker.
Common Synonyms
Klotho, alpha-Klotho, KL, soluble Klotho, s-Klotho, anti-aging factor
Last Reviewed
August 19, 2026

What Klotho is. And where it comes from

Klotho is a transmembrane protein first identified in 1997 when researchers at the National Institute of Neuroscience in Japan found that mice lacking the Klotho gene aged rapidly and died prematurely. The landmark paper, Kuro-o et al. (1997) in Nature, named the protein after Clotho, the Greek Fate who spins the thread of life.

The protein exists in two forms: membrane-bound (acts as a co-receptor for FGF23, regulating phosphate and vitamin D) and soluble/secreted (circulates in blood and cerebrospinal fluid, acting as a hormonal signal). It is the soluble form that has attracted the most interest in longevity and cognitive research.

Dena Dubal's lab at UCSF has been driving the translational research, showing that even a single injection of a Klotho protein fragment enhances cognition in aging mice. A finding that generated significant media attention.

Klotho is one of the few molecules where the animal longevity data is so striking that it has attracted serious academic attention. But striking animal data has burned us before. The question is whether it translates to humans, and we do not know yet.

Peptexa editorial note

Mechanism, in plain English

Klotho influences several pathways implicated in aging and neurodegeneration.

IGF-1
Suppresses insulin/IGF-1 signaling, the most conserved longevity pathway across species
ROS
Reduces oxidative stress, enhances antioxidant defense and cellular resilience
GluN
Enhances NMDA receptor-dependent synaptic plasticity, cognitive function in animal models
FGF23
Modulates FGF23/phosphate metabolism, mineral homeostasis and vascular calcification

Want all 32 Anti-Aging & Longevity compounds in one place?

The Peptexa Anti-Aging & Longevity guide covers every compound in this category, mechanism, evidence level, and FDA status for each.

Get the Guide →

What the evidence shows

Animal data (strong): Mice overexpressing Klotho live 20-30% longer. Klotho-deficient mice show accelerated aging across every organ system. A single injection of Klotho protein fragment enhances cognition in aging mice and in young mice (Dubal lab, UCSF). These are robust, replicated findings.

Human data (very early): Observational studies show that people with a specific Klotho gene variant (KL-VS heterozygotes) have higher circulating Klotho levels, better cognitive function, and larger brain regions. However, no interventional human trial has been conducted, nobody has injected Klotho into a human to test whether it improves cognition or extends healthspan.

Evidence level: ★★☆☆☆, primarily preclinical. The animal signal is among the strongest in longevity research. Human translation is at the observational and biomarker stage.

Klotho may be the most promising anti-aging molecule that nobody can buy. It is not a small peptide you synthesize cheaply, it is a large protein requiring sophisticated production. That is both a limitation and a protection against premature commercialization.

Peptexa editorial note

FDA status

No Klotho-based therapeutic is FDA-approved or in human clinical trials. Klotho is primarily studied as a biomarker of aging and a research tool.

Unity Biotechnology and academic groups are exploring therapeutic applications, but no IND (Investigational New Drug) application for Klotho has been publicly announced. Last reviewed 2026-08-19.

Common synonyms researchers use

Klotho · alpha-Klotho · KL · soluble Klotho (s-Klotho) · KL-VS (the longevity gene variant). Named after Clotho, the Greek Fate who spins the thread of life.

Safety & adverse-event landscape

No human safety data exists because no human interventional trial has been conducted. Animal studies show Klotho overexpression extends lifespan without obvious toxicity, but overexpression is not the same as exogenous administration.

Klotho modulates insulin/IGF-1 signaling, phosphate metabolism, and Wnt pathways. All of which have complex downstream effects. Theoretical risks of exogenous Klotho administration are not characterized.

Peptexa is an educational resource. We do not provide dosing guidance, sourcing recommendations, or protocol advice. Always consult a qualified healthcare provider before any decision involving a peptide or therapeutic compound.

Frequently asked questions

Klotho is a protein discovered in 1997 that plays a role in aging. Mice without Klotho age rapidly; mice with extra Klotho live 20-30% longer. It circulates in blood as soluble Klotho and appears to protect against cognitive decline and metabolic aging.
No. Peptexa is educational only. We do not sell or ship any peptide or protein product.
No. Klotho is a large protein (1012 amino acids) that cannot be taken orally and is not commercially available as an injectable. It is a research molecule studied in academic labs, not a consumer product.
No. No Klotho-based therapeutic has entered human clinical trials. It is studied as a biomarker and research tool.
KL-VS is a genetic variant of the Klotho gene. People who carry one copy (heterozygotes) have higher circulating Klotho levels and show better cognitive function in observational studies. It is sometimes called the longevity variant.

Want this in your inbox weekly?

Get the Peptexa Top-5 free, five compounds, mechanism-led. One email a week. No spam.

The full Anti-Aging & Longevity reference

32 compounds. Mechanism, evidence level, and regulatory status for every one.

Get the Anti-Aging & Longevity Guide →